Bayer Seeks To Toss Fraud Claims From Trasylol MDL

Law360, New York (August 19, 2008, 12:00 AM EDT) -- Bayer AG has asked a judge to dismiss fraud claims from a multidistrict lawsuit against the drugmaker over its now-recalled Trasylol, a drug used to reduce blood loss during surgery, saying that the plaintiffs have not pleaded the claim with sufficient particularity.

Lawsuits over the drug have been piling up since early 2007, a few months after the U.S. Food and Drug Administration said that Bayer had failed to disclose evidence that the drug increased the chance of kidney failure and death, and the company stopped...
To view the full article, register now.